Research into the development of simple blood tests that can detect cancer is promising. In 2024, researchers developed a panel of sensors that can detect certain enzymes associated with lung cancer.
Managing maximum tolerated dose (MTD) chemotherapy while minimizing neutropenia relies on precise complete blood count (CBC) monitoring and AI-powered diagnostics.
Medicare Part B covers clinical diagnostic lab tests, such as a complete blood count (CBC). It may also cover iron infusion as an outpatient procedure if a person meets certain requirements.